|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.318 SEK | -0.90% |
|
+1.54% | -24.03% |
Sprint Bioscience AB (publ) reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported revenue was SEK 1.01 million compared to SEK 0.053 million a year ago. Net loss was SEK 12.28 million compared to SEK 14.21 million a year ago.
Basic loss per share from continuing operations was SEK 0.18 compared to SEK 0.36 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -24.03% | 8.46M | |
| -1.69% | 104B | |
| +3.46% | 97.47B | |
| +5.39% | 22.25B | |
| -13.79% | 21.68B | |
| -9.77% | 18.2B | |
| -39.98% | 17.02B | |
| -11.26% | 16.36B | |
| +7.18% | 14.39B | |
| +38.10% | 12.37B |
SPRINT BIOSCIENCE AB 
